Plant Health Care PLC
LSE:PHC
Plant Health Care PLC
Research & Development
Plant Health Care PLC
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Plant Health Care PLC
LSE:PHC
|
Research & Development
-$2.9m
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
CF Industries Holdings Inc
NYSE:CF
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
FMC Corp
NYSE:FMC
|
Research & Development
-$270.6m
|
CAGR 3-Years
5%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-7%
|
|
|
Corteva Inc
NYSE:CTVA
|
Research & Development
-$1.5B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Scotts Miracle-Gro Co
NYSE:SMG
|
Research & Development
-$37m
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-1%
|
|
|
Mosaic Co
NYSE:MOS
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Plant Health Care PLC
Glance View
Plant Health Care Plc engages in the provision biological products. The company is headquartered in Raleigh, North Carolina and currently employs 45 full-time employees. The company went IPO on 2004-07-06. The firm's segments include Americas, Mexico, and Rest of World. The company offers products to improve the health, vigor and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. Its biological products help growers to protect their crops from stress and diseases. Its lead product, Harpin ab, is a recombinant protein developed from the naturally occurring Harpin proteins, which act as a biostimulant, promoting the yield and quality of crops. The company is also focused on the research and development of its Plant Response Elicitor technology (PREtec) platform. The company is developing six lead products from three platforms, including Innatus 3G platform, which targets growth and disease resistance; T-Rex 3G platform, which targets nematode defense, while the Y-Max 3G platform delivers increased yield and growth.
See Also
What is Plant Health Care PLC's Research & Development?
Research & Development
-2.9m
USD
Based on the financial report for Dec 31, 2023, Plant Health Care PLC's Research & Development amounts to -2.9m USD.
What is Plant Health Care PLC's Research & Development growth rate?
Research & Development CAGR 5Y
7%
Over the last year, the Research & Development growth was 20%. The average annual Research & Development growth rates for Plant Health Care PLC have been 1% over the past three years , 7% over the past five years .
